A case report of severe recurrent varicella in an ankylosing spondylitis patient treated with adalimumab – a new side effect after 15 years of usage
Abstract Background Tumor necrosis factor-α (TNF-α) antagonists, most of which are monoclonal antibodies, became a widespread treatment for autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel diseases, psoriasis, psoriatic arthritis, hidradenitis suppurativa...
Main Authors: | Tomislava Skuhala, Anita Atelj, Jelena Prepolec, Mahmoud Al-Mufleh, Andrija Stanimirović, Dalibor Vukelić |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-02-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-019-3768-y |
Similar Items
-
Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
by: Tatyana Valentinovna Mezenova, et al.
Published: (2012-04-01) -
EXPERIENCE OF ADALIMUMAB TREATMENT IN PATIENT WITH JUVENILE ANKYLOSING SPONDYLITIS AND UVEITIS
by: E. V. Mitenko, et al.
Published: (2012-02-01) -
Criptosporidiose em paciente com espondilite anquilosante usando adalimumabe Cryptosporidiosis in a patient with ankylosing spondylitis treated with adalimumab
by: Fernando Augusto Chiuchetta
Published: (2010-06-01) -
Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab
by: Dubravka Bosnić, et al.
Published: (2016-12-01) -
Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis
by: Zena Chen, et al.
Published: (2021-09-01)